Real-world data show that GLP-1 receptor agonists (GLP-1s) may reduce metastatic progression of certain obesity-related ...
EMERALD-3: Phase III trial of IMFINZI ® (durvalumab) in combination with IMJUDO ® (tremelimumab-actl), with or without lenvatinib, and transarterial chemoembolization (TACE) in patients with ...
Recent research has found that GLP-1 class obesity and diabetes treatments, such as Wegovy and Mounjaro, may improve ...
AstraZeneca advances its ambition to eliminate cancer as a cause of death and transform outcomes for people living with rare diseases with new data ...
The human body has some brutal survival limits, and medicine has documented them in detail. Certain body parts can be removed ...
After being diagnosed with a rare bile duct cancer, a dad feared his toddler son might grow up without him until his cousin ...
There have been many years of rhetoric about finding a cure for cancer. Are we any closer and what will drive the numbers ...
Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced new retrospective data showing that Noetik’s artificial intelligence-based TARIO-2 model identified spatial tumor ...
Sichuan Kelun-Biotech Biopharmaceutical said on Thursday its experimental treatment combined with partner Merck's Keytruda ...
An oral medication already approved for thrombocytopenia in patients with liver disease significantly improved platelet ...
Doctors used words such as "inoperable" and "incurable," effectively telling me that this cancer would kill me sooner or later.
Compared to people without liver steatosis, those with the condition had greater noncalcified coronary plaque burden and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results